Sansure Biotech Inc. (688289.SS)
CNY 22.2
(0.0%)
CNY 22.2
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 112.82 Million | 2.55 Billion | 1.87 Billion | 2.64 Billion | 22.4 Million | 10.06 Million |
| Net Income | 363.72 Million | 1.93 Billion | 2.24 Billion | 2.61 Billion | 39.47 Million | 6.76 Million |
| Depreciation & Amortization | 136.76 Million | 89.07 Million | 53.94 Million | 26.68 Million | 20.64 Million | 20.11 Million |
| Deferred income taxes | 41.12 Million | -39.95 Million | -8.06 Million | -4.64 Million | 663.59 Thousand | 3.88 Million |
| Stock-based compensation | 6.17 Million | 60.84 Million | 5.6 Million | - | 7.78 Million | 7.35 Million |
| Change in working capital | -123.05 Million | 203.31 Million | -402.12 Million | -50.38 Million | -49.68 Million | -28.1 Million |
| Other non-cash items | -330.45 Million | 308.94 Million | -14.8 Million | 49.37 Million | 3.52 Million | 11.29 Million |
| Investing Cash Flow | 1.48 Billion | -1.16 Billion | -1.11 Billion | -1.71 Billion | -94.6 Million | 77.51 Million |
| Investments in PPE | -391.34 Million | -558.82 Million | -372.86 Million | -108.66 Million | -34.14 Million | -32.9 Million |
| Acquisitions | 47.72 Million | -11.59 Million | 15.94 Million | 115.04 Million | 359.76 Thousand | 575.16 Thousand |
| Investment purchases | -7.43 Billion | -12.14 Billion | -7.87 Billion | -3.72 Billion | -195 Million | -100 Million |
| Sales/Maturities of investments | 9.22 Billion | 11.59 Billion | 7.12 Billion | 2.11 Billion | 130.93 Million | 100.73 Million |
| Other Investing Activities | 40.74 Million | -46.86 Million | -909.3 Thousand | -108.66 Million | 3.24 Million | 109.1 Million |
| Financing Cash Flow | -529.11 Million | -915.94 Million | -688.59 Million | 1.6 Billion | 44.39 Million | 1.03 |
| Debt repayment | -5 Million | -17.18 Million | -55 Million | -55 Million | - | - |
| Dividends payments | -400.07 Million | -647.23 Million | -449.31 Million | -300 Million | - | - |
| Common Stock Repurchased | -122.73 Million | -257.4 Million | -200 Million | - | - | - |
| Common Stock Issuance | - | 274.58 Million | 200 Million | - | - | - |
| Other Financing Activities | 4.61 Million | -259.01 Million | -193.69 Million | 1.96 Billion | 44.39 Million | - |
| Accounts receivables | 376.54 Million | -496.51 Million | -304.14 Million | -419.38 Million | -33.76 Million | -45.83 Million |
| Accounts payables | - | 496.51 Million | 3.11 Million | 585.72 Million | -7.81 Million | 28.9 Million |
| Inventory | -78.29 Million | -282.1 Million | -93.03 Million | -212.07 Million | -8.77 Million | -15.05 Million |
| Other working capital | -421.29 Million | 485.42 Million | -8.06 Million | -4.64 Million | 663.59 Thousand | -13.04 Million |
| Cash at beginning of period | 3.21 Billion | 2.63 Billion | 2.59 Billion | 99.16 Million | 127.01 Million | 39.53 Million |
| Cash at end of period | 4.23 Billion | 3.09 Billion | 2.63 Billion | 2.59 Billion | 99.16 Million | 127.01 Million |
| Capital Expenditure | -391.34 Million | -558.82 Million | -372.86 Million | -108.66 Million | -34.14 Million | -32.9 Million |
| Effect of forex changes on cash | 344.78 Thousand | -10 Million | -34.25 Million | -44.58 Million | -46.42 Thousand | -104.96 Thousand |
| Net cash flow / Change in cash | 1.02 Billion | 466.24 Million | 42 Million | 2.49 Billion | -27.84 Million | 87.47 Million |
| Free Cash Flow | -278.52 Million | 2 Billion | 1.5 Billion | 2.53 Billion | -11.73 Million | -22.83 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 38.72 Million | 75.68 Million | 81.02 Million | 363.72 Million | 63.99 Million | 208.04 Million |
| Depreciation & Amortization | - | 40.97 Million | 40.97 Million | 136.76 Million | 35.6 Million | -51.77 Million |
| Deferred income taxes | - | - | - | 41.12 Million | - | 512.76 Million |
| Stock-based compensation | - | 15.89 Million | - | 6.17 Million | 6.17 Million | -8.09 Million |
| Change in working capital | - | -17.46 Million | - | -123.05 Million | 256.08 Million | -480.9 Million |
| Other non-cash items | 35.22 Million | 31.84 Million | -198.18 Million | -330.45 Million | 191.24 Million | -232.91 Million |
| Investing Cash Flow | 201.79 Million | 31.68 Million | -216.69 Million | 1.48 Billion | 679.8 Million | 1.02 Billion |
| Investments in PPE | -61.31 Million | -86.43 Million | -30.61 Million | -391.34 Million | -174.74 Million | -41.71 Million |
| Acquisitions | 118.5 Thousand | -58.12 Million | 27.3 Thousand | 47.72 Million | 47.35 Million | 95.5 Thousand |
| Investment purchases | -124 Million | -524.49 Million | -732.25 Million | -7.43 Billion | -447.95 Million | -3 Billion |
| Sales/Maturities of investments | 386.98 Million | 700.73 Million | 546.15 Million | 9.22 Billion | 1.2 Billion | 4.08 Billion |
| Other Investing Activities | 118.5 Thousand | -58.12 Million | -177.59 Million | 40.74 Million | 51.82 Million | -11.07 Million |
| Financing Cash Flow | -145.59 Million | -126.17 Million | 421.05 Million | -529.11 Million | -150.82 Million | 406.33 Thousand |
| Debt repayment | - | -5.58 Million | -394.13 Million | -5 Million | -5 Million | - |
| Dividends payments | -144.5 Million | -113.85 Million | -130.6 Thousand | -400.07 Million | -152.8 Million | -2.43 Million |
| Common Stock Repurchased | - | - | - | -122.73 Million | -122.73 Million | - |
| Common Stock Issuance | 1.38 Million | 20.06 Million | - | - | - | - |
| Other Financing Activities | -1.09 Million | -140.65 Million | 26.92 Million | 4.61 Million | 382.89 Million | 2.84 Million |
| Accounts receivables | - | 14.41 Million | - | 376.54 Million | 376.54 Million | -467.06 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -15.33 Million | - | -78.29 Million | -78.29 Million | -13.83 Million |
| Other working capital | - | -16.53 Million | - | -421.29 Million | -42.15 Million | - |
| Cash at beginning of period | 4.22 Billion | 4.33 Billion | 4.23 Billion | 3.21 Billion | 3.46 Billion | 2.45 Billion |
| Cash at end of period | 4.33 Billion | 4.31 Billion | 4.33 Billion | 4.23 Billion | 4.23 Billion | 3.42 Billion |
| Capital Expenditure | -61.31 Million | -86.43 Million | -30.61 Million | -391.34 Million | -174.74 Million | -41.71 Million |
| Effect of forex changes on cash | -2.62 Million | -105.64 Thousand | -1.82 Million | 344.78 Thousand | -3.1 Million | -3.42 Million |
| Net cash flow / Change in cash | 106.39 Million | -15.77 Million | 97.33 Million | 1.02 Billion | 771.16 Million | 968.11 Million |
| Free Cash Flow | 12.62 Million | -19.88 Million | -147.78 Million | -278.52 Million | 44.89 Million | -94.59 Million |
7608
1258
RYSMF
GULFPETRO
ICICIGI
034590